Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors

NCT04118114 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Hepatocellular Carcinoma
Advanced Solid Tumor

Interventions

DRUG: PRL3-zumab

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]